May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Angiogenic Inhibitor Plasminogen Kringle 5 Down-Regulates the Expression of Vascular Endothelial Growth Factor in Müller Cells
Author Affiliations & Notes
  • C. Shao
    Ophthalmology, Storm Eye Inst, Charleston, SC, United States
  • S.X. Zhang
    Ophthalmology, Storm Eye Inst, Charleston, SC, United States
  • J. Fant
    Ophthalmology, Storm Eye Inst, Charleston, SC, United States
  • Y. Chen
    Ophthalmology, Storm Eye Inst, Charleston, SC, United States
  • B. Rohrer
    Ophthalmology, Storm Eye Inst, Charleston, SC, United States
  • J. Ma
    Ophthalmology, Storm Eye Inst, Charleston, SC, United States
  • Footnotes
    Commercial Relationships  C. Shao, None; S.X. Zhang, None; J. Fant, None; Y. Chen, None; B. Rohrer, None; J. Ma, None.
  • Footnotes
    Support  NIH Grant EY12231 EY12600, ADA, JDF
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2879. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Shao, S.X. Zhang, J. Fant, Y. Chen, B. Rohrer, J. Ma; Angiogenic Inhibitor Plasminogen Kringle 5 Down-Regulates the Expression of Vascular Endothelial Growth Factor in Müller Cells . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2879.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Vascular endothelial growth factor (VEGF) plays an important role in retinal neovascularization. Müller cells are a major source of VEGF in the retina. Plasminogen kringle 5 (K5) is known to inhibit retinal neovascularization. This study was designed to determine if K5 regulates VEGF in Müller cells. Methods: A rat Müller cell line (rMC-1) was treated with cobalt chloride (CoCl2 200 µM) to induce VEGF expression and K5 was administered at different concentrations (50, 100, 200, 400 nM) in a serum-free medium. Western blot analysis was used to measure intracellular VEGF levels, and ELISA was used to measure secreted VEGF in the medium. The intracellular VEGF level was normalized by ß-actin and the secreted VEGF level by the total protein concentration. To determine the in vivo effect, rats with oxygen-induced retinopathy (OIR) received intravitreal injections of K5 with different doses (0.3, 1, 3, 10 µg/eye). Immunohistochemistry was performed to determine the expression of VEGF in the retinal Müller cells. Results: In the Müller cell line, CoCl2 significantly increased VEGF levels both in the cells and in the medium. Western blot analysis and ELISA both showed that the expression of VEGF induced by CoCl2 was inhibited by K5 in a concentration-dependent manner. In OIR rats, immunohistochemistry showed that K5 decreased the expression of VEGF in Müller cells. This in vivo effect also appeared to be K5 dose-dependent. Conclusions: These results indicate that K5 decreases the VEGF expression induced by CoCl2 in a Müller cell line and in retinal Müller cells of OIR rats. The K5-induced down-regulation of VEGF in Müller cells may be responsible for its anti-angiogenic activity.

Keywords: hypoxia • Muller cells • growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×